Stock Track | Inspire Medical Systems Plunges 14.30% After-Hours on Weak 2026 Guidance and Reimbursement Challenges

Stock Track

May 05

Inspire Medical Systems' stock experienced a significant after-hours plunge of 14.30% on Monday, following the release of its first quarter 2026 financial results and updated annual guidance.

The company reported Q1 revenue of $204.6 million, which beat analyst estimates of $202 million, but represented only a modest 1.6% year-over-year growth. More concerning for investors was the Q1 GAAP diluted loss per share of $0.39 and a net loss of $11.3 million.

The primary driver behind the sharp decline appears to be the company's 2026 outlook. Inspire Medical Systems guided for full-year revenue between $825 million and $875 million, representing a decrease of 4% to 10% compared to 2025 levels. The company cited ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, as factors limiting revenue growth. Management anticipates this coding and reimbursement uncertainty will persist throughout 2026, negatively impacting results.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1107307766"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1107307766\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1107307766?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 04:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107307766","market":"sg","top_or_hot":-1,"title":"Stock Track | Inspire Medical Systems Plunges 14.30% After-Hours on Weak 2026 Guidance and Reimbursement Challenges","media":"Stock Track","content":"<p>Inspire Medical Systems' stock experienced a significant after-hours plunge of 14.30% on Monday, following the release of its first quarter 2026 financial results and updated annual guidance.</p><p>The company reported Q1 revenue of $204.6 million, which beat analyst estimates of $202 million, but represented only a modest 1.6% year-over-year growth. More concerning for investors was the Q1 GAAP diluted loss per share of $0.39 and a net loss of $11.3 million.</p><p>The primary driver behind the sharp decline appears to be the company's 2026 outlook. Inspire Medical Systems guided for full-year revenue between $825 million and $875 million, representing a decrease of 4% to 10% compared to 2025 levels. The company cited ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, as factors limiting revenue growth. Management anticipates this coding and reimbursement uncertainty will persist throughout 2026, negatively impacting results.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Inspire Medical Systems Plunges 14.30% After-Hours on Weak 2026 Guidance and Reimbursement Challenges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Inspire Medical Systems Plunges 14.30% After-Hours on Weak 2026 Guidance and Reimbursement Challenges\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 04:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Inspire Medical Systems' stock experienced a significant after-hours plunge of 14.30% on Monday, following the release of its first quarter 2026 financial results and updated annual guidance.</p><p>The company reported Q1 revenue of $204.6 million, which beat analyst estimates of $202 million, but represented only a modest 1.6% year-over-year growth. More concerning for investors was the Q1 GAAP diluted loss per share of $0.39 and a net loss of $11.3 million.</p><p>The primary driver behind the sharp decline appears to be the company's 2026 outlook. Inspire Medical Systems guided for full-year revenue between $825 million and $875 million, representing a decrease of 4% to 10% compared to 2025 levels. The company cited ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, as factors limiting revenue growth. Management anticipates this coding and reimbursement uncertainty will persist throughout 2026, negatively impacting results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INSP","symbol_name":"Inspire Medical Systems","start_time":0,"source_url":"","article_id":"1107307766","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107307766","pubTimestamp":1777927236,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Inspire Medical Systems' stock experienced a significant after-hours plunge of 14.30% on Monday, following the release of its first quarter 2026 financial results and updated annual guidance.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INSP":"Inspire Medical Systems"},"translate_title":"个股追踪|Inspire Medical Systems盘后暴跌14.30%，因2026年指引疲弱和报销挑战","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INSP":1},"content_text":"Inspire Medical Systems' stock experienced a significant after-hours plunge of 14.30% on Monday, following the release of its first quarter 2026 financial results and updated annual guidance.The company reported Q1 revenue of $204.6 million, which beat analyst estimates of $202 million, but represented only a modest 1.6% year-over-year growth. More concerning for investors was the Q1 GAAP diluted loss per share of $0.39 and a net loss of $11.3 million.The primary driver behind the sharp decline appears to be the company's 2026 outlook. Inspire Medical Systems guided for full-year revenue between $825 million and $875 million, representing a decrease of 4% to 10% compared to 2025 levels. The company cited ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, as factors limiting revenue growth. Management anticipates this coding and reimbursement uncertainty will persist throughout 2026, negatively impacting results.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}